Skip to main content

Dr. Taha has more than 20 years of experience in R&D, technology commercialization and entrepreneurship in ICT and Nanotechnology. He started his work as an R&D scientist at Intel technology group in Oregon, where he worked for 5 years. Then, between 2007 and 2017, he founded and led the expansion of two startups in the fields of ICT and managed the delivery of more than $200 million of ICT projects. 

He was later appointed as the Executive Chairman of Revonence, a value-add private equity holding group, where he shifted the focus of the group toward nanotechnology commercialization. Between the years 2018 and 2020, Dr. Taha worked closely with Nobel Laureate, Professor Fraser Stoddart, and his team of scientists, on the scaling and commercialization of the CD-MOFs (Cyclodextrin-Based Metal-Organic Frameworks) technology, the only edible and biodegradable MOF known to date. He also led the development of a manufacturing facility, the first of its kind in the world, based in Irvine, California, for the large-scale synthesis, activation, and integration of the organic nanotechnology CD-MOF.

Samer received his PhD in Electrical Engineering from Penn State University and worked at the Center for Research in Knowledge Communications (CRKC) in Pennsylvania, as a postgraduate researcher from 1999 to 2001.